TOPIC
covaxin
‘Cause of death is poisoning, not vaccine’: Bharat Biotech issues clarification after phase 3 trial participant for Covaxin dies in Bhopal
The volunteer from Bhopal in Madhya Pradesh had died 10 days after he had participated in the clinical trial for Covaxin
COVID-19 vaccination in India to start from 16 January, 30 crore including frontline workers, aged and high-risk people to be vaccinated
The vaccination will start after the forthcoming festivals across the country including Lohri, Makar Sankranti, Pongal, Magh Bihu etc
Serum Institute and Bharat Biotech pledge smooth rollout of COVID-19 vaccines in a joint statement, lay controversy to rest: Details
The Indian regulatory body has approved emergency use of both Serum Institute developed Covishield and Bharat Biotech's Covaxin to combat the coronavirus
Dr Gagandeep Kang who cast aspersions on indigenously made COVID-19 vaccines is an anti-Modi Dhruv Rathee fan: Details
Dr Gangandeep Kang was one of the 150 'scientists' who signed a letter indirectly asking the voters to vote against PM Modi in 2019.
PM Modi to review the progress of COVID-19 vaccine development in Ahmedabad, Hyderabad and Pune
During his three-city visit Prime Minister Narendra Modi will review the development and manufacturing of three vaccine candidates by Zydus, Bharat Biotech and Serum Institute of India respectively.
Haryana Health Minister Anil Vij becomes first to get trial dose of India-made COVID vaccine
Haryana Health Minister Anil Vij was administered a trial dose of India made Covaxin at a hospital in Ambala on November 20
Haryana health minister volunteers to be vaccinated as Bharat Biotech’s Covaxin enters phase 3 trials
The phase 3 trial of Covaxin that will be conducted on 26,000 volunteers will be the largest clinical trial for a Covid-19 vaccine candidate in India.
Dear liberal media, please promise to be respectful no matter how Covaxin trial goes
As India begins human trials of coronavirus, the liberal media needs to learn its lessons from its own conduct on how to be respectful, should we not succeed at first go.
ICMR refutes claims of unrealistic goal to release COVAXIN, says it is only cutting red tape, not any necessary clinical process
ICMR issues statement saying its expedited trial for Covaxin will bypass only red tape and files, not clinical tests
VHP leader Surendra Jain offers himself for human trials of newly developed coronavirus vaccine COVAXIN
VHP leader Surendra Jain said that he is ready to join human trial for COVAXIN and the institute can him for these trials any time.
